Introduction
There is increasing interest in gene-specific repair studies. This aspect of DNA repair is currently under intense investigation and new laboratories are entering the field. The data are coming in rapidly and we are in the midst of exciting developments. Accordingly, it is premature to build extensive models of the regulation and biological importance of gene specific repair. The purpose of this review is (i) to explain the methodology involved in these studies, (ii) to clarify some established concepts, (iii) to provide an update of the status of gene and strand specific DNA repair and (iv) to point out some of the directions in which the field is moving.
DNA damage
Whereas UV irradiation mainly introduces two lesions into the DNA, the pyrimidine dimer and the 6-4 photoproduct, most other DNA-damaging agents introduce a spectrum of lesions. Some common lesions are schematized in Figure 1 , and some examples will be mentioned. For chemotherapeutic agents, for example, the adducts formed range from simple methylations to complex bulky monoadducts to crosslinks between DNA strands or between DNA and protein. Cisplarin is the prototypical heavy metal compound with antitumor activity, and the most frequent lesion formed is the intrastrand adduct between adjacent purines (GG or AG) (1) . The interstrand crosslinks acount for only -1 % of the total DNA lesions (2) , and DNA protein crosslinks can also occur at low frequencies. AJkylating agents include simple monofunctional methylating agents such as methylmethanesulfonate aid bifunctional agents such as nitrogen mustard, which forms both monoadducts and interstrand DNA crosslinks. The two predominant lesions are the alkylations of the N 1 and O 6 positions of guanine but many other base modifications are possible and the spectrum varies for the individual agents (3) . Bleomycin, an antitumor antibiotic, intercalates into DNA and produces free radicals which then create both single-and doublestrand breaks in DNA (4) . Psoralen is a naturally occurring compound that binds to DNA and forms two types of photoadducts after exposure to UVA light: monoadducts and interstrand crosslinks. PUVA (psoralen plus UVA light) has been used to treat the malignancy mycosis fungoides and other dermatological disorders, notably psoriasis. Other environmental carcinogens cause a number of bulky adducts in DNA.
•Abbreviations: XP, xeroderma pigmentosum; BrdUrd, bromodeoxyuridine; DHFR, dflrydrofolate reductase; 4NQO, 4-nitroquinoline-l-oxide; ADA, adenosine deaminase; NAAAF, JV-acetoxy-acetylaminofluorene.
DNA repair pathways
The DNA repair processes are a complex set of reactions that in a sense act as an immune surveillance system at the DNA level, recognizing and removing a multitude of adducts from the genetic material. Based on estimations in Escherichia coli, as many as 30% of all genes are in one way or another involved in these processes, and it is thus likely that a sizeable number of the 10 5 mammalian genes are involved in some aspect of these mechanisms. In the human DNA repair-deficient disorder, xeroderma pigmentosum (XP), there are now eight documented complementation groups, suggesting at least that number of different genes in the early steps of UV excision repair. In yeast, at least 50 DNA repair-deficient mutants have been identified. A number of human repair genes have been cloned (for recent review, see 5); from the sequence of these genes it appears that many of the products are helicases, but complete characterization awaits the isolation and biochemical studies of these repair enzymes.
The major forms of DNA repair include direct reversal, excision repair and post-replication repair. The most common and most relevant form of DNA repair to this discussion is excision repair which is the pathway of repair for a wide range of DNA lesions. Two basic types of excision repair have been described in bacteria (6) . One system, base excision repair, removes smaller types of base damage such as some lesions caused by ionizing radiation or monofunctional alkylating agents. Another system, nucleotide excision repair, removes bulky DNA adducts of which the UV-induced pyrimidine dimer is the prototype. The basic steps involved in excision repair are shown in Figure 2 . They include: (i) preincision recognition of DNA damage, (ii) incision of the damaged DNA strand near the defect, (iii) excision of the defective site with concomitant degradation of the excised DNA strand, (iv) replication of a repair patch to replace the excised strand with the opposite (intact) strand being used as a template and (v) ligation of the repair patch at its 3' end. The resulting patch in nucleotide excision repair is much larger (20-100 bases) than in base excision repair (1 -5 bases).
Although some of the enzymes involved in prokaryotic DNA repair have been characterized, their mammalian counterparts are less well described. Two prokaryotic enzymes, T4 endonuclease V and uvr ABC excinuclease, play roles in the excision pathways of E. coli and have proven particularly useful in the study of gene-specific repair. The T4 endonuclease V, which recognizes cyclobutane pyrimidine dimers, has both DNA glycosylase and AP endonuclease activities resulting in a singlestranded nick in DNA at the site of a pyrimidine dimer ( Figure  2A ). This enzyme has been used in our assay for gene-specific repair (7) . The E.coli ABC excinuclease, encoded by the urvA, uvrB and uvrC genes, recognizes a wide range of bulky DNA adducts. These proteins act in concert to accomplish the first three steps of excision repair: recognition, incision and excision, as outlined in Figure 2 (B). This enzyme has also been used in genespecific repair studies because the damage formed by several 
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• chemotherapeutic agents, including cisplatin, mitomycin C and psoralen, can be recognized by the enzyme (8) .
Genome organization and gene-specific DNA repair In considering the relevance of gene-specific DNA repair it is appropriate to reflect on some aspects of nuclear structure. The DNA of the mammalian cell is highly organized and packaged into higher-order chromatin structures. Figure 3 illustrates the basic levels of DNA organization. The DNA in the nucleus (A) represents the overall genome and it is at this level that most DNA repair studies have been carried out. But as shown in Figure  3 , higher-order structure loops of the chromosome, the nuclear matrix (C), the nucleosomes (D), the double helix (E) and its base constitutents (F) all represent levels for precise regulation and control of the DNA for replication, transcription and repair. The complex packaging and 50 000-fold compression of the DNA in the nucleus plays a major role in the regulation of transcription and replication and is bound also to affect the regulation of DNA repair processes. In fact, evidence is mounting that the DNA repair processes are intimately linked with these other DNArelated processes, and this will in part be discussed later. Genes are juxtapositioned to the nuclear matrix (C) at times of transcription and replication and possibly DNA repair. After low doses of UV damage, the repair label is found in the nuclear matrix associated fraction, whereas after higher doses of UV there is no such association (9) . At the level of the core and linker regions (D) there is now some information about damage and repair (10) . The inset in Figure 3 shows replicating and transcribing DNA sequences as they relate to DNA repair, to be discussed in the following. Almost all of the work in DNA repair over the last decades has been done by measuring the events in the total genome. It is now established that there is considerable intragenomic heterogeneity of the DNA repair processes and this will affect our thinking and experimentation in this field. Since the genes only constitute a small fraction of the overall genome (<1%), any changes in gene-specific repair would not be detected using traditional assays at the level of the overall genome.
Methodology
The prototype gene-specific repair technique was first developed to study the repair of UV damage by quantitating the removal of pyrimidine dimers in gene fragments. The process will be summarized here, but for a more complete protocol, see Bohr and Okumoto (11) . The key is to generate a lesion-specific strand break at the site of the damage and then measure the formation and repair of the strand breaks by quantitative Southern analysis. A flow diagram of the procedure used for quantifying DNA adducts is shown in Figure 4 . In the standard UV experiment, the cells are prelabeled with [ separation in an equilibrium gradient. After irradiation with UV light at 254 nm, the cells are allowed to repair in the presence of bromodeoxyuridine (BrdUrd) to density label the replicated DNA. The DNA is extracted and purified from each sample and restricted with the appropriate restriction endonuclease to detect later the fragment of interest. The parental DNA is then separated from the semiconservatively replicated DNA by CsCl equilibrium gradient centrifugation. In this experiment, as in other repair assays, it is important to remove the replicated DNA, which would otherwise be measured as repaired. At this point, the DNA is treated with the T4 endonuclease V enzyme to generate singlestranded breaks at the pyrimidine dimers and the sample is run in parallel with non-treated sample on an alkaline gel, transferred to a nylon membrane and probed for the sequence of interest. A ratio of the treated and untreated DNA band intensities gives the fraction of single strands that are free of damage (the zero class) and the number of lesions per fragment is calculated based on the Poisson distribution. An example of the type of data generated with this approach is shown in Figure 5 . The formation and repair of pyrimidine dimers is shown in the dihydrofolate reductase (DHFR) 5' gene fragment, G in Figure 6 . Alternative methods for measuring gene-specific repair have been reported. An antibody toward a specific adduct or toward BrdUrd which is incorporated in the repair patch can be used to precipitate selectively DNA fragments that contain damage or, respectively, that are repaired (12) . These assays require good antibodies and a high degree of sensitivity; and to be quantitative, the antibody must detect and co-precipitate a DNA fragment containing only one lesion or BrdUrd substitution. When the BrdUrd antibody is used, it has the advantage that it can detect the repair of a number of different lesions, but has the disadvantage that the initial level of damage cannot be determined.
Lately, polymerase chain reaction (PCR) methods have been developed where the repair of small gene fragments can be measured. In an early report by Govan et al. (13) , a very high dose of 3 kJ/m 2 was used, rendering experimental conditions non-physiological. But there are indications that this approach can now be used at more physiological levels by using other agents and by using larger gene fragments for the studies. It is a promising approach, and has the advantage that various lesions . Methodology for gene-specific repair analysis of adducU and crosslinks. The steps are described in the text. For adducts, the key point is to create strand breaks (cf. Table I ) at sites of damage, and then resolve the single-stranded DNA in alkaline gels for Southern probing and analysis, cf. can be studied using the same approach. In yet another approach, Bianchi et al. (14) studied the cutting by restriction endonucleases at rare sites in the c-myc gene. Lesions formed at the recognition sequence after UV damage block the cutting, and the loss and reappearance of an extra band can thus be detected by Southern analysis. In this method, the replicated DNA is not distinguished from the repaired, and the pyrimidine dimer sites cannot be distinguished from those of other photoproducts. However, this method can be used to detect a broad spectrum of DNA lesions.
Preferential DNA repair
It was initially shown that the active, essential DHFR gene was repaired very efficiently after UV damage in hamster cells where the overall genome repair was low (7). This phenomenon has been called 'preferential DNA repair', and it has been observed for a number of active genes in various mammalian cell lines (15) . In human cells, the overall genome DNA repair is proficient, and repair is almost complete in 24 h. The preferential repair of the active gene is manifested as a faster repair rate than in the overall genome, but unlike rodent cells, all genomic regions are proficiently repaired. These and other characteristics involved in preferential repair are shown in Figure 7 to clarify the concept. 7 that genes can be repaired at faster rates than the DHFR gene, as exemplified by the repair of the c-myc gene in a human cell line. In addition, Figure 7 incorporates another aspect about the preferential DNA repair: the lack of preferential repair in the human disease Cockayne's syndrome. This condition is associated with severe mental retardation, dwarfism and hypersensitivity to UV irradiation. Cells from these patients have normal overall genome repair, but genes are repaired no more efficiently than inactive genomic regions (16) . This further illustrates the importance of measuring DNA repair at the level of the gene: the defect in repair in this disease can only be determined by such studies. Of interest is also that Cockayne's cells may harbor a mutation for a gene product involved in gene-specific DNA repair.
Preferential DNA repair is a general feature in many biological systems. It has been observed in various mammalian cell lines, in fish, yeast (17) and in E.coli (18) . Its presence in bacteria suggests that the preferential DNA repair of active genes is not dependent upon chromatin structure. Preferential DNA repair in active genes is not limited to tissue culture cells: results show that active genes are repaired more efficiently than inactive in mouse skin (H.Ruven, personal communication).
A DNA repair domain
From the studies on the fine structure of DNA repair of UV damage in the hamster DHFR gene, it appeared that the region of preferential repair was larger than the size of the gene. Whereas the gene has a size of ~ 30 kb, the domain of preferential DNA repair was -60-80 kb (19). Since this is the size of the higher-order structures in chromatin, it is possible that DNA repair is regulated within such chromatin loops. In a study on the repair of UV damage in the hamster metallothionein genes, the increased repair after gene activation was also observed in a region much larger than the gene (20) . The pattern of repair thus may appear to follow some aspect of chromatin structure that regulates the accessibility of the repair proteins. One parameter to consider is the degree of genomic demethylation; there are very few studies on the relation of DNA repair to genomic methylation patterns, and only one study at the gene level. It was observed that genomic demethylation could affect the pattern of repair in the hamster DHFR domain (21) .
Strand specificity
As an extension of the previously described technique (Figure  4 ), single-stranded probes (riboprobes) can be used in place of the double-stranded probes, normally used in these experiments. With this approach, it was observed that the preferential DNA repair of pyrimidine dimers after UV damage in the hamster DHFR gene was largely due to repair of the transcribed DNA strand, whereas the non-transcribed strand was unrepaired (22) . This strand bias of the repair of pyrimidine dimers has been observed in other mammalian genes in different laboratories and has also been found in the yeast trp gene (10) and in the lacl gene of E.coli (18) . Recent results from our laboratory indicate that the strand selectivity of the repair processes is far more distinct for the pyrimidine dimer and possibly limited to the repair of a few lesions. For a number of other lesions that we have studied in the hamster DHFR gene, to be discussed later, the strand bias is much less distinct. For example, there appears to be very little if any strand bias in the repair of 6 -4 photoproducts (23) and of the UV-mimicking agent 4-nitroquinoline-l -oxide (4NQO) (24) . N 1 lesions formed by the monofunctional alkylating agent dimethylsulfate are repaired with equal efficiency from the two strands (23, 25) , whereas we find a strand bias in the repair of cisplatin intrastrand adducts (23) . The degree of strand bias in the repair process may relate to the degree with which the lesion blocks the transcription process. While it is established that UV blocks transcription in vivo, it is not so clear whether transcription can bypass other lesions. The finding that DNA repair can be strand biased has led to the proposal that there may be a 'transcription coupling factor' that associates the repair enzymes with the transcription mechanism (26) .
Strand bias of mutations
It has been observed in several mammalian genes that there can be a strand bias in the formation of mutations, and this is most likely due to strand-selective repair. After treatment with UV or benzo[a]pyrene, more mutations are formed in the nontranscribed strand than in the transcribed strand of the human HPRT gene (27) (28) (29) . In the hamster DHFR gene, mutations induced by benzo[c]phenanthrene diolepoxide are also preferentially located in the non-transcribed strand (30) . For UV there seems to be a reasonable correlation between the strand bias of the DNA repair and the strand bias of the mutations as studied collectively in the HPRT gene (31) . One limitation is that whereas the gene-specific repair can now be measured for both pyrimidine dimers and 6-4 photoproducts (see later), the type of photoproduct that caused the mutation in wild-type cells cannot easily be distinguished. In repair-deficient XP complementation group A cells, McGregor et al. (28) reported that there is no strand bias of the repair; this supports the notion that the strand-selective repair process is responsible for the strand bias of the mutations. It is important, however, to consider that since these mutations are fixed by replication, the strand bias could also arise from a bias in replication after damage. It is further possible that some situations with strand bias of mutations arise from strand-specific repair and others arise from replication bias. This may depend upon the location of the origin of replication in relation to the sequence studied. Although the site of the origin of replication is known for many genes, it is further possible that this location changes after DNA damage. It will require further study to resolve this important relationship between the repair process and the mutational spectrum, and the best approach would seem to be co-ordinated studies of gene-specific and strand-specific DNA repair and of mutations in the same gene in the same biological system.
Gene-specific DNA repair and transcription
Several experiments have shown that the efficiency of repair in a gene can correlate to its transcriptional activity. Gene-specific DNA repair efficiency of pyrimidine dimers can be modulated by transcriptional induction of structural genes such as in the case of the hamster or human metallothionein genes (32, 33) and inhibitors of transcription can block the gene-specific repair (34) . As with UV-induced pyrimidine dimers, gene-specific repair of alkylation damage can also correlate with transcriptional activity: in rat cells, there was substantially more repair of N-methylpurines in the active insulin gene than when it was not transcribed (35) . In these and other studies, the transcription was assayed by Northern analysis, and we are still awaiting repair studies where the rate of transcription is studied more directly by nuclear run-on experiments.
The strand specificity of pyrimidine dimer repair discussed above further documents the association between DNA repair processes and the transcription complex. This association appears to be more evident for the strand specificity of the repair than for the gene-specific repair. J.Venema et al. (personal communication) have recently shown that gene-specific and strand-specific DNA repair can be uncoupled: in the normal human adenosine deaminase (ADA) gene there is preferential repair and strand-specific repair after UV damage. However, in a patient with severe combined immunodeficiency disease harboring a mutation in the ADA gene promoter, which results in the gene being transcriptionally silent, there is still preferential gene-specific repair, but no strand specificity of this repair. In vitro methods are now available (36) where gene-and strandspecific repair can be studied in cell-free systems. It is possible to begin to identify protein fractions that contain this coupling factor, and it may not be long before the protein(s) involved have been characterized. For the following discussion gene-specific (preferential) repair needs to be distinguished from strand-specific repair. Whereas the strand specificity of the repair of pyrimidine dimers appears to be closely associated with transcription, there are data suggesting that the gene-specific repair efficiency may not always correlate with transcriptional activity (37) . In addition, in differentiating mouse cells, it has been demonstrated that the gene-specific repair of some genes correlate with the stage of differentiation rather than with gene expression (38) .
Levels of gene-specific repair
As shown in Figure 7 , there are significant differences in the repair efficiency in different genes. With respect to repair, different genomic regions may be categorized from the lowest to the highest repair efficiency as follows: (i) the inactive genomic DNA, (ii) the inactive genes that are turned off early in development, (iii) the structural genes that are capable of transcription at certain times in metabolism, (iv) the essential genes that are always active but at a low level of transcription, and finally (v) an active gene transcribed at a high rate. This is obviously speculative and needs to be explored.
Another consideration is the degree of local cytosine methylation of the genome, it has been suggested that active genomic regions are undermethylated and many genes and other regions have been mapped by isoschizomeric restriction analysis to determine the sites of demethylation. There has been very little experimentation on the correlation between the degree of methylation and DNA repair. In a study by Ho et al. (21) , we found that the overall genomic DNA repair can increase significantly after treatment of cells for many generations with azacytidine (75% demethylation of the genome). Of further interest was the marked change in the pattern of gene-specific repair; in our previously discussed DNA repair domain in the hamster DHFR gene, the 3' end of the gene was now repaired as efficiently as its 5' end after extensive genomic demethylation. The important determinant here might be the chromatin structural changes that occur after changes in the methylation pattern of DNA.
Specific inhibitors
One approach to searching for the specific enzymes involved in the preferential repair has been to use specific enzyme inhibitors in the assay. In a comparative study, the effect of a number of inhibitors were determined on the gene-specific repair in the hamster DHFR gene and also for the overall genome repair and replication (39) . A number of compounds that inhibit overall genome repair such as inhibitors of topoisomerase I and II have no effect on the gene-specific repair after UV damage. However, a combination of topoisomerase I and II inhibitors do inhibit the gene specific repair of pyrimidine dimers (T.Stevsner and V.A.Bohr, in preparation). This would suggest that one topoisomerase can take over from the other in the gene-specific repair process. Caffeine, which among other effects is thought to abrogate the DNA-damage-induced G2 arrest, also have an inhibitory effect on the gene-specific repair of pyrimidine dimers, with no effect on the overall genome repair (40) . Finally, the RNA polymerase inhibitor a-amanitin also specifically inhibits gene-specific repair after UV damage (34) . These inhibitor experiments are at this point only guideposts for models, but they certainly suggest that the enzymology involved in gene-specific repair has dissimilarities from that involved in the repair in the average genome.
Gene-specific repair of lesions other than pyrimidine dimers
Using variations of the above technique a number of lesions other than pyrimidine dimers have been studied at the level of the gene. Table I shows approaches used to create strand breaks at the site of the specific lesions. For the detection of the rare, but important UV-induced 6-4 photoproduct, a combination of photolyase treatment and cleavage with ABC excinuclease has been utilized (41) . Cisplatin intrastrand adducts and a number of carcinogens (such as 4NQO and N-acetoxy-acetylaminofluorene; NAAF) can be detected by cleavage with ABC excinuclease. Alkylating agents can be detected by a direct chemical reaction thus circumventing the use of an enzyme: the strand breaks are generated by neutral heat depurination followed by alkaline hydrolysis (25, 42, 43) . The interstrand crosslinks are detected and quantitated in a slightly different manner as shown on the left side of Figure 4 . Samples are denatured and reannealed before electrophoresis on neutral gels. After Southern probing, two bands (Figure 4 and 8) are detected, one representing the double-stranded (crosslinked) DNA fragment and the other the native fragment (single-stranded).
The preferential repair of a number of lesions has been studied in the hamster DHFR domain, comparing the repair in the active gene with the repair in the downstream, non-coding region ( Figure 6G and N) . For the data shown in Figure 9 , the genespecific repair is probed in the DHFR gene fragment, and the membrane is stripped and reprobed for the downstream fragment, which was shown to be non-transcribed by Northern analysis (K.Wassermann and V.A. Bohr, unpublished) . This latter fragment was chosen because it might reflect the repair of the overall genome (which is 99% non-coding). Also, it is located within the DHFR domain 3' to the gene and it conveniently has the same size as the fragment studied in the DHFR gene. Figure  9 shows the time course of repair of some important lesions. For Figure 3) . Hamster cells were treated with cisplatin and the repair was analyzed in the 14 kb (G) fragment of the DHFR gene ( Figure 6 ). Non-denatured samples are run as controls, d, double-stranded DNA (crosslinked); s, singlestranded DNA (native). The repair is visualized as the disappearance of double-stranded DNA with time and the corresponding increase in native (repaired) DNA.
pyrimidine dimers (PD), it is evident that there is preferential repair, i.e. there is much more repair in the DHFR gene (G) than in the non-coding region (N) at both 8 and 24 h. 6-4 photoproducts (PP) are repaired much more efficiently from the non-coding region than are pyrimidine dimers, but there is still preferential repair of this lesion (41).
Gene-speciflc DNA repair
Differential DNA Repair of some Lesions 1CXH Fig. 9 . Time course of repair of different lesions in the hamster DHFR domain, the active gene (G) and the non-coding region (N) are mapped in Figure 6 . PD, pyrimidine dimer; PP, 6-4 photoproduct; NF, N-acetoxyacetylaminofluorene (NAAAF); CX, cisplatin interstrand crosslinks; CA, cisplatin intrastrand adducts; NM, nitrogen mustard; DS, dimethylsulfate. y-axis is percentage repair, and the repair periods are 8 and 24 h as shown.
Cisplatin
As mentioned previously, the intrastrand adduct is by far the most common lesion after treatment of cells with cisplatin. We consistently find some preferential repair of this lesion ( Figure  9 , CA) (44) in the hamster cells, but it is much less distinct than the preferential repair of the pyrimidine dimers (44). Whereas we find that the cisplatin interstrand crosslinks are removed faster from the DHFR gene than are the intrastrand adducts, as shown in Figure 9 , there is no preferential repair of the cisplatin interstrand crosslink (CX) in the hamster DHFR domain (44) .
Alkylating agents
Using the neutral depurination reaction followed by alkaline hydrolysis, we mainly detect guanine N 1 alkylations. Figure 9 shows that the nitrogen mustard (NM) lesions are preferentially repaired in the hamster DHFR domain (42) , while lesions introduced with dimethylsulfate (DS) are not (25, 42) . In addition, lesions introduced with methylnitrosurea were preferentially repaired (43) in the same hamster cells. These results show that there are considerable differences in the mode of repair of different alkylating agents. Since these agents all predominantly cause methylpurine formation, the difference in mode of repair may be due to other aspects than the type of lesion formed. It may reflect differences in the mode of reaction of the alkylating agent with DNA (e.g. S N 1 or S N 2 type reaction). More likely it may depend upon the degree of chromatin distortion that these compounds invoke and thereby the recognition enzymes involved; alternatively, it may reflect the degree of transcription blockade by the adducts.
Other compounds
Psoralen plus UVA light (PUVA) initially creates monoadducts, and the DNA can then be reirradiated by UVA light to form crosslinks. By quantitating interstrand crosslinks before and after the reirradiation, both interstrand crosslinks and monoadducts can be measured. Using the previously described methodology, it was demonstrated that the psoralen crosslinks are removed much faster from the DHFR gene than the monoadducts (45) . In another study in both a hamster and a human cell line, the repair of crosslinks was much more efficient in the DHFR gene than in ribosomal genes (46) . This led to the proposal that preferential repair might be found in polymerase II transcribed genes (DHFR) whereas polymerase I (rDNA) transcribed regions would be repaired less efficiently. However, further confirmation is needed to support this hypothesis. Bleomycin single-and double-strand breaks have been detected at the gene level and repair of single-strand breaks has been quantified in the human c-myc gene (47) . Using the methodology shown in Figure 4 , other types of crosslinks have been detected. Mitomycin-induced crosslinks have been quantitated in human ribosomal genes (48) .
The described methodology has also been used to study DNA damage and repair following carcinogen exposure. DNA adducts produced by the carcinogen NAAAF were repaired with similar efficiency in the DHFR gene and in the non-coding region (49) . (Figure 9, NF) , and the carcinogenic 4NQO adducts are also not preferentially repaired in the hamster DHFR gene (24) . The mechanism of repair of DNA damage induced by these two agents is thought to be UV mimicking, and it is surprising that there is no clearly demonstrable preferential repair.
Drug resistance
The development of drug resistance is a common and serious problem, particularly when treating with cisplatin or alkylating agents (50) . For example, many patients with advanced stage ovarian cancer initially respond well to therapy with cisplatin and then subsequently become resistant to such therapy at relapse (51) . Several mechanisms are thought to play a role in drug resistance, including membrane alterations of drug uptake or efflux, alterations of drug metabolism, and increased DNA repair. Lately, there is increasing evidence that DNA repair may play a more important role in drug resistance than previously thought. For example, some resistant human ovarian cancer cell lines have been shown to have increased rates of DNA repair when compared with the parental cell lines (52) , but in other studies there is no correlation. The reported studies so far on DNA repair in drug resistance have only been done at the level of the overall genome, and it is relevant to explore gene-specific repair in these systems. In some recent experiments in our laboratory (W.Zhen et al., submitted), the DNA repair in cisplatin-resistant human ovarian cancer cells and in their parental cell line was studied. The repair was examined in both cell lines at the level of the overall genome and in the DHFR gene. This was done separately for the two major cisplatin lesions, the intrastrand adduct and the interstrand crosslink. Whereas no correlation was found between cisplatin resistance and overall genome repair of these lesions, there was more efficient repair of the interstrand crosslinks in the DHFR gene in the resistant than in the parental cell lines. This may indicate a correlation between drug resistance and gene-specific repair, and we are investigating this possibility further. It is certainly suggested that further studies be done at the level of the gene to establish new correlations to drug resistance that were not detectable when DNA repair was measured at the level of the overall genome.
Initial damage formation
An important aspect of the gene-specific repair studies is that inherent in the experiment, the initial damage formation is always assessed as a basis for the repair. For UV damage we have not observed any differences in initial damage formation in any specific genomic region, but for alkylating agents such as nitrogen mustard there can be differences in initial levels of damage. We have found (K.Wassermann, M.Pirsel and V.A.Bohr, in preparation) that there can be at least 2-fold differences in the formation of adducts in different regions, surprisingly, sometimes with more adducts formed in inactive regions. For psoralen crosslink formation, there also appears to be differences in the crosslinking efficiency in different genomic regions (53) . In this case, more crosslinks were formed in the active gene regions than in an inactive gene. More studies of this type obviously need to be done for a variety of DNA lesions. In the future we may be able to screen for chemotherapeutics that are selective for certain genomic regions where it would be desirable to inhibit expression.
Gene-specific repair in human repair-deficient syndromes
There have been studies on gene-and strand-specific repair after UV damage in cells from individuals with human repair-deficient diseases. It is not within the scope of this review to thoroughly discuss those studies, but it is significant that there is now an explanation for the high degree of UV sensitivity in cells from patients with Cockayne's syndrome. As mentioned before, cells from these individuals are UV sensitive, but repair the overall genome normally. The deficiency appears to be a lack of preferential repair of the active genes in these cells (16, M.K.Evans, C.J.Link and V.A.Bohr, unpublished), as shown in Figure 7 . Some gene-specific repair measurements have been performed on cells from XP complementation group C (XPC) patients that show low but detectable overall genome repair of pyrimidine dimers. It has been known for some time that these cells repair in a heterogeneous fashion after UV, and that some regions are repaired more efficiently than others (54) . XPC cells show some preferential repair (55) (56) (57) , and it has been proposed that the residual repair in this cell line stems largely from selective repair of the active genes (57) . A comprehensive study on the gene-specific repair in a number of XP complementation groups is now completed in our laboratory (M.K.Evans etai, in preparation), and other laboratories are also investigating the gene-specific repair in human disorders. Clearly, the gene-specific repair studies are going to be important in furthering our understanding of DNA repair differences in human pathophysiology as well as in diagnosing disease or screening individuals at risk.
Gene-specific repair of oncogenes
It was an early project to investigate the heterogeneity of DNA repair in oncogenes. In mouse cells the repair of the transcriptionally active c-abl gene was compared to that in the inactive c-mos protooncogene, and it appeared that the c-abl gene was 4-fold more efficiently repaired than the c-mos (58) . This could mean that the inactive gene might accumulate more damage or be more susceptible to mutation when the cell undergoes mitosis. We have further explored aspects of damage and repair in protooncogenes, and recent experiments in our laboratory show repair differences in the c-myc gene which may relate to tumor pathogenesis (37) . B-cells from spleen in mice that are either resistant or susceptible to plasmacytomas have been studied with the gene-specific repair technique. The repair efficiency after UV irradiation was studied in the c-myc locus as well as in the DHFR gene in mouse strains that were genetically determined to become resistant or sensitive to plasmacytoma formation (37) (Figure 10 ). Whereas the repair in the DHFR regions and in the coding c-myc region was similar in the two strains, this was not the case in the 5' c-myc region. We found deficient repair in this region in the sensitive mouse strain compared to the resistant before the development of tumors. Since rearrangements occur in this region 5' to c-myc, some relationship may exist between the local genomic DNA repair phenotype and c-myc activation. Interestingly, the efficient repair in the 5' c-myc region in the resistant mouse strain did not appear to be related to increased transcription in this region as we found no major transcripts. In addition, there was no strand bias of the repair, i.e. similar repair efficiencies in the two strands in this region (37) . The importance of this 5' c-myc repair phenotype is further accentuated by the observation that efficient repair in this region correlates to plasmacytoma resistance in inbred mouse strains (E.Beecham et al., in preparation). The possibility exists that the localized repair deficiency plays a key role in the development of malignancy by somehow allowing translocations to occur. This relationship will certainly be further explored in the future. An important question to address in this context is whether the many mutations found in the p53 gene in human tumor cells (59) are due to deficient DNA repair.
Bianchi et al. (14) used another approach to examine the region-specific DNA repair in the human c-myc gene. They studied the cutting by a restriction endonuclease at rare sites in the c-myc gene in human COLO320HSR cells, which carries a 30-to 40-fold amplification of the c-myc gene. They concluded that there is more efficient repair of pyrimidine dimers (total photoproducts were studied) in the 5' flanking region of the c-myc gene than in its coding 3' part or its 3' flanking region.
Mitochondrial DNA repair
Numerous studies have demonstrated a greater accumulation of DNA damage in mitochondrial DNA than in nuclear DNA and reasons for this accumulation have been proposed (50) (51) (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) (62) . One factor that may be involved in the increased vulnerability of mitochondrial DNA is that there appears to be very limited repair of DNA damage in the mitochondrial genome. Early studies did not detect repair of UV-induced pyrimidine dimers (63, 64) or the damage induced by exposure to Af-methyl-JV-nitro-N-nitrosoguanidine or 4NQO (65) . Later studies, however, have demonstrated repair of O^-methylguanine from mitochondrial DNA, suggesting that some repair mechanisms may be operating in mitochondrial DNA (66) . Also, the presence of a number of repair endonucleases in mitochondria, including some that recognize oxy-radical damage (67) , suggested that an excision repair mechanism may be present in mitochondria. Recently, using the gene-specific DNA damage and repair approach, repair of alkali-labile sites within mitochondrial DNA has been demonstrated in a rat cell line following exposure to the nitrosurea streptozotocin (68) . These results provided the first direct evidence that an excision repair mechanism may be functioning in mitochondrial DNA. We have explored the repair of a number of different DNA lesions in the mitochondria] of hamster cells (S.P.LeDoux et al., submitted). There appears to be efficient repair of methylation damage following exposure to methylnitrosourea and dimethysulfate, but nitrogen mustard lesions are not repaired. There is no repair of pyrimidine dimers in mitochondrial DNA after exposure to UV light. However, cisplatin interstrand crosslinks introduced into mitochondrial DNA are repaired efficiently. It thus appears that mitochondria have repair capacity but can only repair certain lesions. We are investigating whether this corresponds to repair pathway, i.e. whether mitochondria have base excision repair capability but not nucleotide excision repair capability. The findings raise many other questions which are now being actively investigated. It seems, for example, important to determine if repair enzymes are transported into the mitochondria.
Conclusions
It is now possible to determine the damage formation and repair of various types of DNA-damaging agents in individual genes. The results obtained so far clearly show that such studies provide us with new and important information that relates DNA repair capability to other biological parameters as well as aspects of malignancy. These relationships often do not appear when DNA repair is studied with more traditional approaches where the events are averaged over the entire genome. The recently discovered phenomenon of preferential repair of active genes after UV damage has provided the framework for understanding the fine structure of DNA repair. There is strong evidence for a linkage between strand specificity of repair and transcriptional activity in a given gene. Preferential repair of a gene can also be linked with transcription, but recent studies suggest that this is not the whole story. We are now able to investigate the genespecific damage and repair for a number of carcinogens and chemotherapeutics, and these studies will hopefully provide insight into the etiology and treatment of malignancies.
